Undefined T cell Deficiency Disorder
Showing 1 - 25 of >10,000
Limbal Stem Cell Deficiency Trial in Toronto, Montréal, Québec (surgical transplantation of CECA)
Recruiting
- Limbal Stem Cell Deficiency
- Surgical transplantation of ACCE
-
Toronto, Ontario, Canada
- +2 more
Jan 20, 2023
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023
Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)
Recruiting
- Hematopoietic Organs; Disorder
- CD62L depleted donor lymphocyte infusion
-
Hong Kong, Hong KongHong Kong Children's Hospital
Sep 6, 2023
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Immunosuppression Only Conditioning
- +3 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Immunodeficiencies Trial in Philadelphia (CliniMACs)
Active, not recruiting
- Immunodeficiencies
- CliniMACs
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 1, 2022
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)
Recruiting
- Cytomegalovirus Infections
- Primary Immune Deficiency Disorder
- viral specific cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Adenovirus
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +8 more
Sep 27, 2022
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Busulfan test dose
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)
Recruiting
- Epstein-Barr Virus Infections
- +2 more
- Group A
- Group B
-
Montreal, Quebec, CanadaHôpital Maisonneuve-Rosemont
Apr 5, 2022
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Subcutaneous Immunoglobulin in Primary and Secondary
Not yet recruiting
- Primary Immune Deficiency Disorder
- Secondary Immune Deficiency
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jun 14, 2022
Primary Immune Deficiency Disorders, Metabolic Disease Trial in Saint Petersburg (Haploidentical Hematopoietic Cell
Recruiting
- Primary Immune Deficiency Disorders
- Metabolic Disease
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 9, 2021
Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic
Enrolling by invitation
- Severe Combined Immunodeficiency (SCID)
- +8 more
- CD3/CD19 negative allogeneic hematopoietic stem cells
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Dec 6, 2021
LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive
Recruiting
- LGLL - Large Granular Lymphocytic Leukemia
- +13 more
-
Duarte, California
- +9 more
Aug 9, 2022